ConductScience.org, home

Paper29947950

Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.

Kim KA and 2 others. Eur J Clin Pharmacol, 2018. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans. Papers, record 29947950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29947950

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2018-12-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kim KAKyoung-Ah
2Park IBIn-Bae
3Park JYJi-Young

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytochrome P-450 CYP2D6Major topic
Cytochrome P-450 CYP3AMajor topic
HemodynamicsMajor topic
Prostatic HyperplasiaMajor topic
TamsulosinMajor topic
Adrenergic alpha-1 Receptor Antagonists
Adult
Biological Availability
Blood Pressure
Humans
Male
Pharmacogenetics
Polymorphism, Genetic

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111740341The genetic determinants of the CYP3A5 polymorphism.Pharmacogenetics2001https://conductscience.org/library/papers/11740341PubMed
216920322Determination of tamsulosin in human aqueous humor and serum by liquid chromatography-electrospray ionization tandem mass spectrometry.J Pharm Biomed Anal2007https://conductscience.org/library/papers/16920322PubMed
312485953The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin.Drug Metab Dispos2003https://conductscience.org/library/papers/12485953PubMed
417213004Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study.Clin Ther2006https://conductscience.org/library/papers/17213004PubMed
524262967Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: a crucial role for the CYP2B6*6 allele.Clin Chim Acta2014https://conductscience.org/library/papers/24262967PubMed
624926778Functional gene variants of CYP3A4.Clin Pharmacol Ther2014https://conductscience.org/library/papers/24926778PubMed
718231117Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations.Clin Pharmacol Ther2008https://conductscience.org/library/papers/18231117PubMed
824088607Recent examples on the clinical relevance of the CYP2D6 polymorphism and endogenous functionality of CYP2D6.Drug Metabol Drug Interact2013https://conductscience.org/library/papers/24088607PubMed
917192506Effect of polymorphic CYP3A5 genotype on the single-dose simvastatin pharmacokinetics in healthy subjects.J Clin Pharmacol2007https://conductscience.org/library/papers/17192506PubMed
1024192967Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology.BMJ2013https://conductscience.org/library/papers/24192967PubMed
1114647405CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers.Pharmacogenomics J2004https://conductscience.org/library/papers/14647405PubMed
1210431214Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment.Trends Pharmacol Sci1999https://conductscience.org/library/papers/10431214PubMed
138810034Absorption, metabolism and excretion of tamsulosin hydrochloride in man.Xenobiotica1996https://conductscience.org/library/papers/8810034PubMed
1420126606Efficacy of alpha-Adrenergic Receptor Blockers in the Treatment of Male Lower Urinary Tract Symptoms.Rev Urol2009https://conductscience.org/library/papers/20126606PubMed
158973992Pharmacokinetics of tamsulosin hydrochloride in patients with renal impairment: effects of alpha 1-acid glycoprotein.J Clin Pharmacol1996https://conductscience.org/library/papers/8973992PubMed
1611279519Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.Nat Genet2001https://conductscience.org/library/papers/11279519PubMed
1716986050Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia.Rev Urol2005https://conductscience.org/library/papers/16986050PubMed
1815220015Randomized, open-label, two-period crossover comparison of the pharmacokinetic and pharmacodynamic properties of two amlodipine formulations in healthy adult male Korean subjects.Clin Ther2004https://conductscience.org/library/papers/15220015PubMed
1919744012Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients.J Clin Pharm Ther2009https://conductscience.org/library/papers/19744012PubMed
2025073735Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms.Expert Opin Drug Saf2014https://conductscience.org/library/papers/25073735PubMed

See all 34 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42474264Pharmacokinetics and Bioequivalence of Tamsulosin Hydrochloride Extended-Release Capsules in Healthy Chinese Volunteers: A Randomized, Open-Label, Crossover Study Under Fasting and Fed Conditions.Clin Pharmacol Drug Dev2026https://conductscience.org/library/papers/42474264PubMed
42367398Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance Athlete.Cureus2026https://conductscience.org/library/papers/42367398PubMed
40863448Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management.J Pers Med2025https://conductscience.org/library/papers/40863448PubMed
40467447[Androgen receptor-targeted therapies - avoid clinically relevant interactions].Aktuelle Urol2026https://conductscience.org/library/papers/40467447PubMed
34751931Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele.Arch Pharm Res2021https://conductscience.org/library/papers/34751931PubMed
34690761Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin.Front Pharmacol2021https://conductscience.org/library/papers/34690761PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP2D61565PubTator's text mininghttps://conductscience.org/library/genes/1565NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
CYP3A51577PubTator's text mininghttps://conductscience.org/library/genes/1577NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29947950

GET https://conductscience.org/api/papers/v1/29947950/references?page=2